MULTICENTRE BRONCHIECTASIS STUDY: A Collaborative And International Study Of Bronchiectasis In Indigenous Children.
Funder
National Health and Medical Research Council
Funding Amount
$1,496,414.00
Summary
Aboriginal children have repeated pneumonia episodes; some get better while others develop bronchiectasis (a chronic lung disease). The risk factors associated with progression to bronchiectasis, and the natural history of bronchiectasis in this population is little known. Given the similarities of these diseases among indigenous populations of affluent countries and to increase study size, a collaborative and international study of Indigenous children (Aboriginal and Torres Strait Islander, New ....Aboriginal children have repeated pneumonia episodes; some get better while others develop bronchiectasis (a chronic lung disease). The risk factors associated with progression to bronchiectasis, and the natural history of bronchiectasis in this population is little known. Given the similarities of these diseases among indigenous populations of affluent countries and to increase study size, a collaborative and international study of Indigenous children (Aboriginal and Torres Strait Islander, New Zealand Maori or Pacific Islander and Alaskan Native) has been initiated. In Indigenous children, we aim to define the natural history of chronic moist cough (those at risk of developing bronchiectasis) and bronchiectasis, identify the risk factors associated with progression from early-mild disease (chronic moist cough) to bronchiectasis and to define the role of continuous antibiotic treatment in the prevention of recurrent pulmonary infections that are very common in these children. We plan to follow up Aboriginal children aged 12 months to 8 years diagnosed with bronchiectasis or chronic moist cough. For those diagnosed with bronchiectasis, after fully informed consent is obtained from the parent(s), the child will be allocated by chance to one of the 2 treatment regimes: (1) Azithromycin once-week or (2) placebo once-week. Children will receive the medication or the placebo for a period of 24 months. All these children will be clinically seen 2x-year by the study's paediatrician and 2x-year by the research nurse for the duration of the study. By documenting, for the first time, the epidemiology and natural history of children with chronic moist cough and bronchiectasis, the study will provide a much-needed rationale for their management. If we can scientifically show that this is true, that Azithromycin is effective in reducing the number of respiratory infections, this would be an achievable advance in the treatment in the field for these children.Read moreRead less
Genetic Associations Of Early Retinal Pathologic Phenotypes: Data Pooling And Meta-analyses Of Multiple Populations
Funder
National Health and Medical Research Council
Funding Amount
$736,481.00
Summary
We aim to use data already collected from multiple population-based studies to investigate the likely pathogeneses of early retinal phenotypes that are either markers for cardiovascular risk or precursors of a blinding condition. Understanding if there are genetic susceptibilities for these phenotypes, and if so, how they together with environmental exposures jointly influence the occurrence of the diseases may be key to reduce the burden from cardiovascular disease and blindness.
Graves’ disease is the most common cause of hyperthyroidism. It leads to long-term impairments in quality of life and has a 40% higher mortality rate compared with the general population. We know surprisingly little about the causes of Graves’ disease. One possible trigger is stressful life events; however, the relationship is yet to be proven. This study will assess whether stressful life events, specifically military deployment, are associated with Graves’ disease.
AusDiab 3: Emerging Risk Factors For And Long-term Incidence Of Cardio-metabolic Diseases
Funder
National Health and Medical Research Council
Funding Amount
$2,616,397.00
Summary
This study will track 11,000 Australian adults over 12 years to determine how many develop diabetes, obesity, kidney and heart disease. The study will develop ways to best predict those who are going to develop these conditions before they have arisen, and will explore a range of novel risk factors to better understand these conditions.
Optimising Large-scale Public Health Interventions To Control Neglected Tropical Diseases
Funder
National Health and Medical Research Council
Funding Amount
$318,768.00
Summary
Neglected tropical diseases (NTD) are a group of health conditions that affect the poorest of the poor, particularly in remote and rural areas. They affect the most vulnerable communities and cause substantial, chronic health harms impairing personal and social development. Several debilitating NTD are common in remote indigenous communities and Pacific islands. I propose a series of studies to investigate new strategies to control NTD in large populations where these diseases are endemic.
Development Of Early Warning Systems For Dengue Fever Based On Socio-ecological Factors
Funder
National Health and Medical Research Council
Funding Amount
$327,402.00
Summary
Global climate change has potentially serious effects on the transmission of dengue. An early warning system (EWS) based on socio-ecological factors will be developed to examine where and when outbreaks of dengue are likely to occur and how the future dengue control strategies and prevention efforts need to be applied and strengthened in Australia. This project will provide a platform for future research on developing and implementing an EWS for dengue in the Asia-Pacific region.
Exploiting Existing Data Sources To Improve The Prevention And Treatment Of Cardiovascular Disease
Funder
National Health and Medical Research Council
Funding Amount
$772,490.00
Summary
My program of research exploits several large databases to answer important issues in the prevention and treatment of cardiovascular disease (CVD), which makes a huge contribution to the burden of illness and premature mortality in Australia. An underlying aim is to provide the evidence base to facilitate improvement of the existing CVD risk assessment guidelines in Australia, for better targeting of clinical advice and treatment.
Although the major risk factors for cardiovascular diseases have been known for decades, and modern-day treatment is much advanced, the importance of these diseases persists, such that they remain the number one killer in Australia. This suggests that more can be done to correctly identify those at high and moderate risk of future disease, so as to optimize advice and medical treatment. This project will use the best evidence available to develop new methods of risk prediction and prevention.
Predicting The Impact Of Current Obesity And Diabetes Trends On Future Prevalence Of Cardiovascular Disease In Australia
Funder
National Health and Medical Research Council
Funding Amount
$222,762.00
Summary
Obesity and diabetes are both strong risk factors for cardiovascular disease. As their prevalence has more than doubled over the past decades we need to know the likely effect on future rates of cardiovascular disease. Here we propose to create projection models for cardiovascular disease in Australia to estimate the future impact of trends in obesity and diabetes.